News ArchivesRead News
Parkinson’s Linked to Low LDL Cholesterol that is Good for Heart
Thursday December 21, 2006
People with Parkinson’s have lower rate of heart attack and stroke
12/20/06(SeniorJournal.com) - Most of us strive to lower our LDL (low-density lipoprotein) cholesterol – that’s the bad stuff for good cardiovascular health. But, a new study by University of North Carolina at Chapel Hill researchers has found that people with low levels of LDL cholesterol are more likely to have Parkinson’s disease than people with high LDL levels. This disorder that affects nerve cells in the part of the brain controlling muscle movement is most common in senior citizens. Earlier studies have found intriguing correlations between Parkinson’s disease, heart attacks, stroke and smoking.
"People with Parkinson’s disease have a lower occurrence of heart attack and stroke than people who do not have the disease," said Dr. Xuemei Huang, medical director of the Movement Disorder Clinic at UNC Hospitals and an assistant professor of neurology in the UNC School of Medicine.
"Parkinson’s patients are also more likely to carry the gene APOE-2, which is linked with lower LDL cholesterol."
And for more than a decade, researchers have known that smoking, which increases a person’s risk for cardiovascular disease, is also associated with a decreased risk of Parkinson’s disease.
These findings led Huang to examine whether higher LDL cholesterol might be associated with a decreased occurrence for Parkinson’s disease, and vice versa.
"If my hypothesis was correct," she said, "lower LDL-C, something that is linked to healthy hearts, would be associated with a higher occurrence of Parkinson’s."
About Parkinson’s Parkinson’s disease is a disorder that affects nerve cells in the part of the brain controlling muscle movement. People with Parkinson’s disease often experience trembling, muscle rigidity, difficulty walking, problems with balance and slowed movements. These symptoms usually develop after age 60, although some people affected by Parkinson’s disease are younger than age 50.
Parkinson’s disease is progressive, meaning the signs and symptoms become worse over time. But although Parkinson’s disease may eventually be disabling, the disease often progresses gradually, and most people have many years of productive living after a diagnosis.
Furthermore, unlike other serious neurological diseases, Parkinson’s disease is treatable. One treatment approach is medications. Another involves an implanted device that stimulates the brain. Other approaches involve surgery.
The results of Huang’s study, published online Dec. 18 by the journal Movement Disorders, confirmed her hypothesis. "We found that lower LDL concentrations were indeed associated with a higher occurrence of Parkinson’s disease," Huang said.
Participants with lower LDL levels (less than 114 milligrams per deciliter) had a 3.5-fold higher occurrence of Parkinson’s than the participants with higher LDL levels (more than 138 milligrams per deciliter).
Huang cautioned that people should not change their eating habits, nor their use of statins and other cholesterol-lowering drugs, because of the results. The study was based on relatively small numbers of cases and controls, and the results are too preliminary, she said. Further large prospective studies are needed, Huang added.
"Parkinson’s is a disease full of paradoxes," Huang said. "We’ve known for years that smoking reduces the risk of developing Parkinson’s. More than 40 studies have documented that fact. But we don’t advise people to smoke because of the other more serious health risks," she said.
Huang and her colleagues recruited 124 Parkinson’s patients who were treated at the UNC Movement Disorder Clinic between July 2002 and November 2004 to take part in the study. Another 112 people, all spouses of patients treated in the clinic, were recruited as the control group. Fasting cholesterol profiles were obtained from each participant.
The researchers also recorded information on each participant’s gender, age, smoking habits and use of cholesterol-lowering drugs.
Huang notes that the study also found participants with Parkinson’s were much less likely to take cholesterol-lowering drugs than participants in the control group. This, combined with the findings about LDL cholesterol, suggests two questions for additional study, Huang said.
"One is whether lower cholesterol predates the onset of Parkinson’s. Number two, what is the role of statins in that? In other words, does taking cholesterol-lowering drugs somehow protect against Parkinson’s? We need to address these questions," she said.
Recent NewsMay 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis
Apr 12 - Obstructive Sleep Apnea Affects Cognition in Parkinson's Disease
Apr 11 - Seattle boxing gym giving hope to Parkinson's patients
Apr 10 - A new rhythm
Apr 10 - Brain cells reprogrammed to make dopamine, with goal of Parkinson's therapy
Apr 6 - FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
Apr 5 - Combatting the isolation of young onset Parkinson's disease
Apr 1 - The Kid is Alright